pantoprazole has been researched along with Acute Disease in 22 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pantoprazole (40 mg) was compared with ranitidine (300 mg) in the treatment of acute duodenal ulcer." | 9.08 | Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. ( Classen, M; Schepp, W, 1995) |
| "To compare the healing rates of acute duodenal ulcer in patients receiving pantoprazole 40 mg or omeprazole 20 mg once daily and to assess drug tolerance." | 9.08 | Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. ( Beker, JA; Bianchi Porro, G; Bigard, MA; Delle Fave, G; Devis, G; Gouerou, H; Maier, C, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 9.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers." | 9.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| " Pantoprazole, 40 mg, was compared with the H2-receptor antagonist ranitidine, 300 mg, in the healing of acute duodenal ulcer." | 9.08 | A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group. ( Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C, 1995) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 7.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 5.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "Treatment with pantoprazole did not have influence on the clinical course of acute pancreatitis." | 5.16 | [Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study]. ( Hong, SP; Kim, WH; Ko, KH; Kwon, CI; Park, PW; Yoo, JH; Yoo, KH; Yoon, H, 2012) |
| "Pantoprazole (40 mg) was compared with ranitidine (300 mg) in the treatment of acute duodenal ulcer." | 5.08 | Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. ( Classen, M; Schepp, W, 1995) |
| "To compare the healing rates of acute duodenal ulcer in patients receiving pantoprazole 40 mg or omeprazole 20 mg once daily and to assess drug tolerance." | 5.08 | Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. ( Beker, JA; Bianchi Porro, G; Bigard, MA; Delle Fave, G; Devis, G; Gouerou, H; Maier, C, 1995) |
| "Pantoprazole appears to be superior to ranitidine in gastric ulcer healing." | 5.08 | Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. ( Hotz, J; Plein, K; Rose, K; Schönekäs, H, 1995) |
| "The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers." | 5.08 | Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995) |
| " Pantoprazole, 40 mg, was compared with the H2-receptor antagonist ranitidine, 300 mg, in the healing of acute duodenal ulcer." | 5.08 | A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group. ( Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C, 1995) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 3.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 1.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "Acute pancreatitis is one such rare gastrointestinal manifestation of acute pancreatitis." | 1.35 | Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis. ( Antony, T; Baburaj, P; Harikrishnan, BL; Louis, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Tas, N | 1 |
| Mengen, E | 1 |
| Goncu, S | 1 |
| Tasar, S | 1 |
| Kiremitci, S | 1 |
| Ucakturk, A | 1 |
| Murthy, RN | 1 |
| Viswanathan, S | 1 |
| Jain, D | 1 |
| El-Kersh, K | 1 |
| Jalil, B | 1 |
| McClave, SA | 1 |
| Cavallazzi, R | 1 |
| Guardiola, J | 1 |
| Guilkey, K | 1 |
| Persaud, AK | 1 |
| Furmanek, SP | 1 |
| Guinn, BE | 1 |
| Wiemken, TL | 1 |
| Alhariri, BC | 1 |
| Kellie, SP | 1 |
| Saad, M | 1 |
| Ullah, W | 1 |
| Mehmood, A | 1 |
| Micaily, I | 1 |
| Khan, MS | 1 |
| van Boekel, GA | 1 |
| Kerkhofs, CH | 1 |
| van de Logt, F | 1 |
| Hilbrands, LB | 1 |
| Ljubičić, N | 1 |
| Pavić, T | 1 |
| Budimir, I | 1 |
| Puljiz, Ž | 1 |
| Bišćanin, A | 1 |
| Bratanić, A | 1 |
| Nikolić, M | 1 |
| Hrabar, D | 1 |
| Troskot, B | 1 |
| Garrido, A | 1 |
| Giráldez, A | 1 |
| Trigo, C | 1 |
| Leo, E | 1 |
| Guil, A | 1 |
| Márquez, JL | 1 |
| Baburaj, P | 1 |
| Antony, T | 1 |
| Louis, F | 1 |
| Harikrishnan, BL | 1 |
| Kofler, S | 1 |
| Shvets, N | 1 |
| Bigdeli, AK | 1 |
| König, MA | 1 |
| Kaczmarek, P | 1 |
| Deutsch, MA | 1 |
| Vogeser, M | 1 |
| Steinbeck, G | 1 |
| Reichart, B | 1 |
| Kaczmarek, I | 1 |
| Cho, SW | 1 |
| Hwang, JT | 1 |
| Oh, TH | 1 |
| Yoo, JH | 1 |
| Kwon, CI | 1 |
| Yoo, KH | 1 |
| Yoon, H | 1 |
| Kim, WH | 1 |
| Ko, KH | 1 |
| Hong, SP | 1 |
| Park, PW | 1 |
| Ra, A | 1 |
| Tobe, SW | 1 |
| Enns, R | 1 |
| Andrews, CN | 1 |
| Fishman, M | 1 |
| Hahn, M | 1 |
| Atkinson, K | 1 |
| Kwan, P | 1 |
| Levy, A | 1 |
| Jacobs-Kosmin, D | 1 |
| Derk, CT | 1 |
| Sandorfi, N | 1 |
| Keyvani, L | 1 |
| Murthy, S | 1 |
| Leeson, S | 1 |
| Targownik, LE | 1 |
| Lin, HJ | 1 |
| Schepp, W | 2 |
| Classen, M | 1 |
| Beker, JA | 1 |
| Bianchi Porro, G | 1 |
| Bigard, MA | 1 |
| Delle Fave, G | 2 |
| Devis, G | 1 |
| Gouerou, H | 1 |
| Maier, C | 2 |
| Hotz, J | 1 |
| Plein, K | 1 |
| Schönekäs, H | 1 |
| Rose, K | 1 |
| Witzel, L | 1 |
| Gütz, H | 1 |
| Hüttemann, W | 1 |
| Cremer, M | 1 |
| Lambert, R | 1 |
| Lamers, CB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Proton Pump Inhibitors on Kidney Transplant Recipients[NCT03123796] | 300 participants (Actual) | Observational | 2016-12-31 | Completed | |||
| PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents (PROTOCOL)[NCT05817721] | 639 participants (Anticipated) | Observational | 2023-05-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 trials available for pantoprazole and Acute Disease
| Article | Year |
|---|---|
Enteral nutrition as stress ulcer prophylaxis in critically ill patients: A randomized controlled exploratory study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Critical Illness; D | 2018 |
[Intravenous proton-pump inhibitor for acute peptic ulcer bleeding--is profound acid suppression beneficial to reduce the risk of rebleeding?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Female; Humans; Injections, Intravenous; Mal | 2008 |
[Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; | 2012 |
Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Ulcer A | 1995 |
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Ad | 1995 |
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 | 1995 |
A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; | 1995 |
14 other studies available for pantoprazole and Acute Disease
| Article | Year |
|---|---|
Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis.
Topics: Acute Disease; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Humans; Pancreatitis; Pantop | 2023 |
Multiple ecchymotic signs in acute pancreatitis.
Topics: Abdomen; Abdominal Pain; Acute Disease; Adult; Analgesics, Opioid; Drug Therapy, Combination; Ecchym | 2020 |
Comprehensive review of acute oesophageal necrosis.
Topics: Acute Disease; Aged, 80 and over; Blood Transfusion; Endoscopy, Digestive System; Esophageal Disease | 2019 |
Proton pump inhibitors do not increase the risk of acute rejection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Biopsy; Female; Follow-Up Studies; Glomerula | 2014 |
North vs south differences in acute peptic ulcer hemorrhage in Croatia: hospitalization incidence trends, clinical features, and 30-day case fatality.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Age Distribution; Aged | 2014 |
[Acute and subacute renal failure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Acute Kidney Injury; Aged; Algorithms; Amlod | 2008 |
Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen, Acute; Acute Disease; Amylases; Diagnosis, Differe | 2008 |
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Case-Control Studies; Drug Interactio | 2009 |
Education and imaging. Gastrointestinal: Scrub typhus induced acute gastric ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Acute Disease; Aged; Anti-Bacterial Agents; | 2010 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; | 2004 |
Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Aged, 80 and over; Anti-Ulcer Agents; | 2004 |
Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Antibodies, Antineu | 2006 |
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and ove | 2006 |
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Aged, 80 and ove | 2007 |